Search results
Stocks to buy: ONGC, TVS Motor, IRFC among 10 stocks that may rise 6-21% in the next 3-4 weeks, say...
Livemint· 45 minutes agoStocks to buy: Investors await the Union Budget and Q1FY25 earnings. Experts recommend looking...
Market outlook July 08: GIFT Nifty hints at quiet start; Asian shares tepid
Business Standard India· 4 hours agoAll you need to know before Indian stocks open for trade on Monday: Globally, bets on a US Fed rate...
Asia shares inch higher as investors confident about US Fed's Sept rate cut
Business Standard India· 4 hours agoAsian stocks inched higher on Monday as investors grew more confident about a September US rate cut,...
Buy or sell: Vaishali Parekh recommends three stocks to buy today — July 8 | Stock Market News
Livemint· 4 hours agoBuy or sell stocks for today: Despite strong global market sentiments on the US Fed rate cut buzz,...
Profit Booking Looms: Top 3 stock picks for healthy returns, says Jigar Patel
CNBC Awaaz· 5 hours agoTraders are advised to close their short-term long positions to capitalize on these gains. Immediate...
Buy ideas for July 8: HDFC Life, Cipla, SJVN; check target prices here
Business Standard India· 5 hours agoHDFCLIFE recently gave a clean breakout on the weekly chart, signalling a potential bullish trend....
As monsoon sets in, respiratory, malaria drugs see demand rise
The Economic Times· 11 hours agoNew Delhi: The onset of monsoon boosted sales of drugs for respiratory, anti-infective, anti-malaria...
Budget 2024: Wishlist of the pharma industry
rediff.com· 11 hours agoThere is a need to incentivise R&D investments, offer corporate tax concessions and establish an effective intellectual property rights regime in order...
Union Budget 2024 wish list: Tax benefits for pharma, IPR, infrastructure status for hotels
Hindustan Times· 13 hours agoIndia's pharmaceuticals and hospitality sectors expect tax concessions and a lot of support out of...
Indian pharmaceutical market registers over 8% growth in June 2024
Business Standard India· 19 hours agoGSK's antibiotic drug Augmentin and USV's anti-diabetic drug Glycomet GP continued to be the...